Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-20

Clinical Trial Update: Comparison of the Duration of Ropivacaine Combined With Dexmedetomidine or Dexamethasone on Paravertebral Block [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing duration of ropivacaine adjuvants dexmedetomidine vs dexamethasone in paravertebral block for lung cancer patients has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Dexmedetomidine (Dexmedetomidine)
  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: China Medical University, China | Conditions: Lung Cancer | Phase 4 | Status: COMPLETED